REGULATORYThe Marijuana Herald
FDA removes 510(k) requirement for qualifying cannabinoid drug tests
FDA expanded a Class II premarket-notification exemption to qualifying cannabinoid tests used in federal workplace and insurance testing programs, effective October 6. The change may lower a device-market barrier and support future oral-fluid testing, but Oklahoma employers and laboratories still must follow all other FDA and SAMHSA requirements.
Published Oct 6, 2026
Read the full article at The Marijuana Herald#national#testing#employment#compliance
Read the original source
Leafy summaries provide industry context. Confirm details with The Marijuana Herald.